The independent source for health policy research, polling, and news.
1,761 - 1,780 of 15,253 Results
Framed in the rhetoric of choice, Tennessee’s new law governing childhood vaccinations is among more than a dozen recently passed or pending nationwide that set parental freedom against community and children’s health.
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
California Attorney General Rob Bonta has thrown his weight behind state Sen. Monique Limón’s legislation to bar unpaid medical bills from showing up on consumer credit reports. If passed, California would join just a few other states with such protections.
On this episode of “An Arm and a Leg,” host Dan Weissmann breaks down the complicated and expensive world of Medicare with practical tips to pick the right plan and avoid penalties.
Price worries, bureaucratic obstacles, and “I’m-over-covid-itis” slow uptake of a drug that’s complicated to take but often effective.
President Joe Biden used his roughly 68-minute address to Congress to counter lackluster public approval ratings and draw clear contrasts between his administration’s policies and those of Donald Trump and some congressional Republicans. Abortion and health care were in the spotlight.
The historically troubled White House Medical Unit is just one part of a government health system that gives VIP care to top officials, military officers, military retirees, and families. Pentagon investigators say some were prioritized over rank-and-file soldiers.
The cyberattack on a unit of UnitedHealth Group’s Optum division is the worst on the health care industry in U.S. history, hospitals say. Providers struggling to get paid for care say the response by the insurer and the Biden administration has been inadequate.
A court expert reported that California prisons continue to lag on 14 of 15 suicide prevention measures, and even regressed in some areas. The state could face more than $40 million in fines after a federal judge warned more than a year ago that she would impose penalties for each violation.
At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden’s health agenda. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
Despite growing awareness that the party drug is dangerous, the social media company is open to promotion of the drug in treating mental health.
A recent report finds half of America’s rural hospitals are losing money, and many are struggling to stay open. Researchers and advocates worry the hospitals’ financial spiral will have immediate and long-term health effects on their communities.
Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.
After the 1996 Dickey Amendment halted federal spending on research into firearms risks, a small group of academics pressed on, with little money or political support, to document the nation’s growing gun violence problem and start to understand what can be done to curb the public health crisis.
A mathematical model designed to direct spending of opioid settlement funds is at the center of a debate over whether to invest in technology to guide long-term decisions or focus on the immediate needs of people in addiction.
A recently unsealed lawsuit alleges Aledade Inc. developed billing software that boosted revenues by making patients appear sicker than they were.
© 2026 KFF